NCT04373239

Brief Summary

Investigators will examine trends in ART use in BC specifically. The use of ART has drastically changed the management of infertility, with worldwide estimates exceeding 1.8 million ART cycles in 2010 alone. Moreover, an excess of six million children have been conceived using ART. Although various countries have published their live birth rates associated with common ART treatment strategies, British Columbia has yet report on its rates. With varying differences in ART practices, whether clinical or laboratory, it is expected live birth rates due to ART to vary depending on region analyzed. Analyzing the live birth rate in BC would not only allow for a benchmark for assessing future improvement, and trends in infertility diagnosis and management, but also allow for comparison to other provinces and countries. The aim of this part of the study is to describe ART cycle contribution to live birth rate in BC from April 2008 to March 2018, which has not been addressed in the literature as of yet. Not only will it give healthcare providers and patients information about this emerging approach to infertility but also provide a impetus for healthy policy makers to adopt a model for partially or fully publicly funded ART, as seen in Ontario and soon Quebec.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2008

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

April 29, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 4, 2020

Completed
Last Updated

December 13, 2024

Status Verified

April 1, 2020

Enrollment Period

9.9 years

First QC Date

April 29, 2020

Last Update Submit

December 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Live birth rate

    Live birth rate

    Date of delivery

Study Arms (2)

Women in BC conceiving by ART

All women in BC registered in the Perinatal Services BC database having undergone Assisted Reproductive Technology. Assisted Reproductive Technology will consist of in vitro fertilization (+/-ICSI). Data from April 1, 2008 to March 31 2018 will be analyzed for live birth rate.

Procedure: Assisted Reproductive Technology

Women in BC conceiving spontaneously

he comparison group will be all women in BC registered in the Perinatal Services BC database with spontaneously conceived pregnancies between April 1, 2008 to March 31 2018.

Interventions

Assisted reproductive technology includes IVF and IVF+ICSI.

Women in BC conceiving by ART

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All women registered in Perinatal Services BC database with live births between April 2008 and March 2018.

You may qualify if:

  • Nulliparous women registered in Perinatal Services BC database with live birth between April 2008 and March 2018

You may not qualify if:

  • multiparous women
  • women with missing data in Perinatal Services BC database including gravid, parity, age, date of birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Reproductive Techniques, Assisted

Intervention Hierarchy (Ancestors)

Reproductive TechniquesTherapeuticsInvestigative Techniques

Study Officials

  • Mohamed Bedaiwy, MD, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
9 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

April 29, 2020

First Posted

May 4, 2020

Study Start

April 1, 2008

Primary Completion

March 1, 2018

Study Completion

March 1, 2018

Last Updated

December 13, 2024

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share